2019 | | Comparisons of the Mucosal Healing Process between Flat and Protruded Type after Endoscopic Submucosal Dissection for Gastric Neoplasms | 김순선, 김진홍, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 조효정, 황재철 |
2018 | | Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis | 김순선, 김영배, 정재연, 조성원 |
2018 | | FRI-151: Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2007 | 김순선, 노오규, 정재연, 조성원, 조효정 |
2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
2018 | | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects | 김순선, 김진홍, 양민재, 임선교, 정재연, 조성원, 조효정 |
2018 | | Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B | 김순선, 박래웅, 양민재, 정재연, 조성원, 조효정 |
2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
2017 | | Response to Dr Giannini et al | 김순선, 정재연, 조성원, 조효정 |
2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
2017 | | Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population | 조성원 |
2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
2016 | | Evaluation of the Effectiveness of NK Vue Gold Kit in Patients with Chronic Hepatitis B | 김순선, 임영애, 정재연, 조성원 |
2016 | | Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis | 조성원 |
2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
2016 | | Endoscopic naso-gallbladder drainage versus gallbladder stenting before cholecystectomy in patients with acute cholecystitis and a high suspicion of choledocholithiasis: a prospective randomised preliminary study | 김순선, 김욱환, 김지훈, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
2016 | | Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B | 김순선, 박주한, 정재연, 조성원, 조효정 |
2015 | | Anti-rods and rings autoantibodies in a patient with hepatitis C virus infection. | 임영애, 조성원 |
2015 | | Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population. | 정재연, 조성원 |
2015 | | Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. | 정재연, 조성원 |
2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
2015 | | Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance. | 김순선, 신성재, 유병무, 정재연, 조성원, 조효정 |
2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
2014 | | Embolization of percutaneous transhepatic portal venous access tract with N-butyl cyanoacrylate. | 김봉완, 김순선, 김진우, 왕희정, 원제환, 정재연, 조성원 |
2014 | | Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma. | 김순선, 안선주, 우현구, 정재연, 조성원, 조효정 |
2014 | | Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication | 정재연, 조성원 |
2014 | | Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma. | 정재연, 조성원 |
2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
2014 | | Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. | 김순선, 안선주, 임선교, 정재연, 조성원, 황재철 |
2014 | | MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B | 정재연, 조성원 |
2014 | | Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B | 김순선, 김영배, 박주한, 안선주, 정재연, 조성원, 조효정 |
2013 | | Association between Interferon-Inducible Protein 6 (IFI6) Polymorphisms and Hepatitis B Virus Clearance | 정재연, 조성원 |
2013 | | Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients | 김순선, 정재연, 조성원 |
2013 | | Efficacy and safety of entecavir plus carnitine complex (GODEXⓇ) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study | 정재연, 조성원 |
2013 | | Caspase-cleaved fragments of cytokeratin-18 as a marker of inflammatory activity in chronic hepatitis B virus infection. | 김순선, 김영배, 배창범, 신성재, 안선주, 정재연, 조성원 |
2013 | | A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. | 정재연, 조성원 |
2013 | | Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. | 정재연, 조성원 |
2013 | | Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population. | 정재연, 조성원 |
2013 | | Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B. | 김순선, 정재연, 조성원 |
2013 | | How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas? | 김동훈, 김진홍, 신성재, 유병무, 유준환, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
2013 | | Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. | 김순선, 정재연, 조성원 |
2013 | | Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22. | 김경민, 김순선, 박선, 정재연, 조성원, 최용준 |
2012 | | Revision and update on clinical practice guideline for liver cirrhosis | 김재근, 정재연, 조성원 |
2012 | | Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis | 정재연, 조성원 |
2012 | | G-Protein Beta3 Subunit C825T Polymorphism in Patients With Overlap Syndrome of Functional Dyspepsia and Irritable Bowel Syndrome | 이광재, 임선교, 정재연, 조성원 |